1/19
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
clotting factor replacement
factor ____ (type A)
factor ____ (type B)
VII, IX
Aminocaproic acid, tranexamic acid
fibrinolysis inhibitors
fibrinolysis inhibitors MOA
inhibit thrombolytic process
vitamin K supplements MOA
accelerate clotting proces
adverse effects of this cateogry: ____ issues, ____ problems, ____ toxicity, ____, blood ____, _____
GI, neuromuscular, liver, pancreatitis, dyscrasias, arrythmias
statins decrease _____ biosynthesis
cholesterol
statins will decrease ____ and ____, may also decrease ____ and increase ____
LDL, VLDL, triglycerides, HDL
fibric acids decreases ___ and increases ____ breakdown
triglyceride, VLDL
Cholestyamine category
other antilipid agent
Cholestyamine MOA
decrease plasma cholestrol
Niacin category
other antilipid
Niacin decreases ____ and ____ synthesis, increases _____
VLDL, LDL, triglyceride
Probucol catgeory
antilipid agents
Probucol increase ____ breakdown
LDL
Atorvastatin, Fluvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin
statins
statins MOA
inhibit HMG-Co reductase synthesis
Clofibrate, Gemfibrozil category
fibric acids
Cholestyramine MOA
increase GI excretion of bile acids
Probucol MOA
inhibit arterial fat deposition
Niacin is a ____
vitamin